ECTRIMS 2024 Late Breaking Poster.

This document provides summaries of several research studies related to multiple sclerosis (MS). The first study suggests that targeting genetic factors could potentially lead to improved treatments for MS. The second study highlights the potential genetic basis of pediatric-onset MS. The third study investigates the association of immunoglobulin A synthesis with disease activity and neuroaxonal injury in MS patients. The final study explores the use of machine learning models to predict clinical outcomes in MS patients. These studies contribute to our understanding of MS and may inform future research and clinical practice. [Extracted from the article]